Global Hypoactive Sexual Desire Disorder (HSDD) Treatment Market Size By Treatment Type, By Gender, By Distribution Channel, By Geographic Scope And Forecast
Hypoactive Sexual Desire Disorder HSDD Treatment Market
Global Hypoactive Sexual Desire Disorder (HSDD) Treatment Market Size By Treatment Type, By Gender, By Distribution Channel, By Geographic Scope And Forecast
Published Date: August - 2024 | Publisher: MIR | No of Pages: 320 | Industry: latest updates trending Report | Format: Report available in PDF / Excel Format
Global Hypoactive Sexual Desire Disorder (HSDD) Treatment Market Size By Treatment Type, By Gender, By Distribution Channel, By Geographic Scope And Forecast
Hypoactive Sexual Desire Disorder (HSDD) Treatment Market Size And Forecast
Hypoactive Sexual Desire Disorder (HSDD) Treatment Market size was valued at USD 1.9 Billion in 2023 and is projected to reach USD 4.3 Billion by 2030, growing at a CAGR of 14 % during the forecast period from 2024-2030.
Global Hypoactive Sexual Desire Disorder (HSDD) Treatment Market Drivers
The market drivers for the Hypoactive Sexual Desire Disorder (HSDD) Treatment Market can be influenced by various factors. These may include
Growing Awareness Patients’ and healthcare professionals’ increasing knowledge of hypoactive sexual desire disorder (HSDD) is fueling the market’s expansion.
Growing Prevalence Globally, HSDD is becoming more common in both men and women, which is helping to drive market growth.
Technological Developments The market is expanding due to improvements in treatment modalities and diagnostic methods, including pharmaceutical and non-pharmacological ones.
Aging Population There is an increased need for treatment options due to the aging population’s increased susceptibility to sexual dysfunctions, including HSDD, especially in developed nations.
Changing Lifestyles Sexual dysfunctions like HSDD are made worse by modern lifestyles marked by stress, sedentary behavior, and bad eating patterns, which increase the need for treatment.
Growing Healthcare Expenditure More treatment options for HSDD are available due to rising healthcare costs, particularly in emerging economies.
Regulatory Support The market is expanding thanks to regulatory rules that are favorable to the approval and marketing of medications and therapies used in HSDD therapy.
Growing Acceptance People are becoming less stigmatized and more inclined to seek treatment for HSDD as a result of the growing acceptance of sexual health issues as real medical concerns.
Patient Education Initiatives By educating the public about HSDD, advocacy groups and healthcare organizations are increasing awareness and motivating people to get treatment.
Strategic Partnerships The market is expanding as a result of partnerships between pharmaceutical companies and academic institutions to create cutting-edge HSDD treatments.
Global Hypoactive Sexual Desire Disorder (HSDD) Treatment Market Restraints
Several factors can act as restraints or challenges for the Hypoactive Sexual Desire Disorder (HSDD) Treatment Market. These may include
Limited Treatment Options One obstacle to the market’s expansion is the scarcity of FDA-approved medications that are expressly prescribed for the treatment of HSDD.
High Treatment Costs The high costs of pharmacological therapy, in particular, for treating HSDD, may impede market expansion, particularly in poorer nations.
Side Effects Unfavorable side effects linked to certain HSDD therapy medications may discourage patients and hinder their acceptance in the market.
Social Stigma People may be discouraged from seeking diagnosis and treatment if there is a persistent social stigma associated with sexual health disorders, such as HSDD.
Underdiagnosis Patients’ unwillingness to discuss sexual health issues with healthcare practitioners and a lack of awareness might lead to an underdiagnosis of HSDD, which can limit market growth.
Regulatory Obstacles Tight regulations requiring the approval of medications and therapies for HSDD therapy may prevent new products from entering the market and impede innovation.
Psychological Factors Treatment and management of HSDD are made more difficult by the intricate interaction of psychological factors, such as interpersonal problems and stress, that contribute to the disorder.
Preference for Non-pharmacological Therapy The commercial potential for drug-based therapy may be limited by the preference of some persons for non-pharmacological approaches to the treatment of HSDD.
Healthcare Infrastructure Access to HSDD diagnosis and treatment options may be restricted in some areas due to inadequate healthcare infrastructure and resources.
Ethical Issues The use of pharmaceutical therapies to treat HSDD and the medicalization of sexual desire are two ethical issues that may affect the market’s acceptance and uptake.
Global Hypoactive Sexual Desire Disorder (HSDD) Treatment Market Segmentation Analysis
The Global Hypoactive Sexual Desire Disorder (HSDD) Treatment Market is Segmented on the basis of Treatment Type, Gender, Distribution Channel, and Geography.
Hypoactive Sexual Desire Disorder (HSDD) Treatment Market, By Treatment Type
Pharmacological Therapy Including drugs such as flibanserin, bremelanotide, and testosterone replacement therapy.
Non-pharmacological Therapy Including psychotherapy, couple therapy, and lifestyle modifications.
Hypoactive Sexual Desire Disorder (HSDD) Treatment Market, By Gender
Male HSDD Treatment Specific treatments tailored for males experiencing hypoactive sexual desire disorder.
Female HSDD Treatment Treatments designed for females diagnosed with hypoactive sexual desire disorder.
Hypoactive Sexual Desire Disorder (HSDD) Treatment Market, By Distribution Channel
Hospital Pharmacies Medications dispensed through hospital pharmacies under the supervision of healthcare professionals.
Retail Pharmacies Over-the-counter and prescription medications are available at retail pharmacies for patient convenience.
Online Pharmacies There is an increasing trend of purchasing medications online, offering convenience and privacy for patients.
Hypoactive Sexual Desire Disorder (HSDD) Treatment Market, By Geography
North America Including the United States and Canada, known for advanced healthcare infrastructure and high prevalence of HSDD.
Europe Encompassing countries like Germany, the UK, and France, with increasing awareness and treatment options for HSDD.
Asia Pacific Emerging market for HSDD treatment, driven by growing healthcare expenditure and rising awareness.
Latin America Witnessing increasing adoption of HSDD treatment options, supported by improving healthcare infrastructure.
Middle East and Africa Growing recognition of sexual health issues and expanding access to HSDD treatment options.
 Key players
The major players in the Hypoactive Sexual Desire Disorder (HSDD) Treatment Market are
Pfizer Inc. (US)
Endoceutics, Inc. (Canada)
AMAG Pharmaceuticals, Inc. (US)
Sprout Pharmaceuticals, Inc. (US)
Palatin Technologies, Inc. (US)
S1 Biopharma, Inc. (US)
Emotional Brain BV (Netherlands)
Yuppie Medical (Switzerland)
Mylan N.V. (US)
Report Scope
REPORT ATTRIBUTES
DETAILS
STUDY PERIOD
2020-2030
BASE YEAR
2023
FORECAST PERIOD
2024-2030
HISTORICAL PERIOD
2020-2022
UNIT
Value (USD Billion)
KEY COMPANIES PROFILED
Pfizer Inc. (US), Endoceutics, Inc. (Canada), AMAG Pharmaceuticals, Inc. (US), Sprout Pharmaceuticals, Inc. (US), Palatin Technologies, Inc. (US), S1 Biopharma, Inc. (US), Emotional Brain BV (Netherlands).
SEGMENTS COVERED
By Treatment Type, By Gender, By Distribution Channel, By Geography
CUSTOMIZATION SCOPE
Free report customization (equivalent to up to 4 analyst working days) with purchase. Addition or alteration to country, regional & segment scope
Top Trending Reports
Research Methodology of Market Research
To know more about the Research Methodology and other aspects of the research study, kindly get in touch with our .
Reasons to Purchase this Report
We'll dive deep into the market with both qualitative and quantitative analyses, looking at everything from money to more nuanced, human factors. You'll get hard numbers—market value in USD Billion—for every piece of the puzzle. We'll pinpoint which region and segment are set to explode, and where the action's hottest. Expect a geographical breakdown, showing where the product/service is being lapped up and what's driving demand in each place. We'll also map out the competitive landscape, ranking the big players and tracking all the major moves (new launches, partnerships, expansions, acquisitions) from the last five years. Then, we'll give you extensive profiles – think company overview, insights, product comparisons, and SWOT analysis – for all the key companies. We’ll wrap it up with a view into the present and future, covering growth opportunities, drivers, challenges, and restraints in both up-and-coming and established markets. And, of course, we'll break down the market from every angle using Porter's five forces, giving you insights through the Value Chain. Finally, we'll explore market dynamics and upcoming growth possibilities, plus you'll get 6 months of post-sales analyst support to help you navigate it all.
Customization of the Report
• In case of any please connect with our sales team, who will ensure that your requirements are met.
For a single, multi and corporate client license, the report will be available in PDF format.
Sample report would be given you in excel format. For more questions please contact:
Sample Report for Global Hypoactive Sexual Desire Disorder (HSDD) Treatment Market Size By Treatment Type, By Gender, By Distribution Channel, By Geographic Scope And Forecast
